Subrat Kumar Tripathy

Subrat Kumar Tripathy

Auto-generated profile, based on publicly available information

Subrat Kumar Tripathy

Department of Biochemistry, IMS & SUM Hospital, Siksha ‘O’ Anusandhan University Bhubaneswar-751003, Odisha, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
SISadhni Induar
Sadhni Induar
DDDebasmita Dubey
Debasmita Dubey
SRShakti Rath
Shakti Rath
RMRajesh Kumar Meher
Rajesh Kumar Meher
SSSantosh Kumar Swain
Santosh Kumar Swain
STSubrat Kumar Tripathy
Subrat Kumar Tripathy
Dioscorea alata belongs to Dioscoreaceae or the yam family. Around 600 Dioscorea species are consumed in various regions of the world. Dioscorea alata is well known cultivated tuber consumed by both rural and urban people. In this study, we have investigated the nutrient composition, phytochemicals, and antioxidant and antimicrobial activity of the underground and aerial tubers of Dioscorea alata. The result of the analysis showed that the aerial tuber of D. alata contained a higher amount of moisture (68.51%), ash (4.64%), starch (5.61%), reducing sugar (0.029%), fat (0.33%) and protein (1.39%) than underground tuber of D. alata. At the same time, carbohydrates, free amino acids, vitamin C, sodium, potassium and iron contents were superior in the underground tuber than in the aerial tuber. Further, both underground and aerial tuber was a good source of phenols, flavonoids, tannins and diosgenin. The underground tuber exhibited better DPPH scavenging potential compared to the aerial tuber. Six solvents extract of D. alata showed significant to moderate antibacterial activity toward seven tested clinical stains. Thus, the tuber of D. alata could be used as a better food supplement to meet the calorie requirement and a rich source of relevant antimicrobial agents to treat microbial infections.

1 August 2025 in AL-Kindy College Medical Journal
Verified
Journal Article
Open access
PDF file
PSPranamita Sahu
Pranamita Sahu
DDDebasmita Dubey
Debasmita Dubey
SPSoumya Surath Panda
Soumya Surath Panda
STSubrat Kumar Tripathy
Subrat Kumar Tripathy
Obesity is a significant risk factor for colorectal cancer (CRC), influencing its development through multiple biological pathways. Elevated levels of insulin, insulin-like growth factor-1 (IGF-1), leptin, resistin, and inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) contribute to colonic cell proliferation and tumor formation. Additionally, obesity-induced hormonal imbalances, including decreased adiponectin and ghrelin, further increase CRC risk. Changes in gut microbiota due to obesity also play a role in carcinogenesis, highlighting the complex interplay between metabolic, inflammatory, and microbial factors. This review explores the pathophysiological mechanisms linking obesity to CRC, emphasizing its role as a modifiable risk factor. Insulin resistance, chronic inflammation, oxidative stress, and dysregulated adipokine secretion are key contributors to CRC progression in obese individuals. By analyzing molecular and epidemiological evidence, this review underscores the importance of early CRC screening for obese individuals, along with lifestyle modifications such as weight loss, dietary improvements, and increased physical activity. Furthermore, microbiome-targeted interventions, including probiotics and prebiotics, may help counteract obesity-driven dysbiosis and reduce CRC risk. Emerging biomarkers and therapeutic targets offer potential for developing obesity-specific CRC treatments. Given the rising global burden of CRC, integrating preventive healthcare strategies, public health initiatives, and clinical interventions is essential for reducing its incidence and improving patient outcomes. Addressing obesity through targeted preventive measures can significantly lower CRC-related morbidity and mortality, making it a crucial aspect of cancer prevention and management